Form 8-K - Current report:
SEC Accession No. 0001193125-23-294938
Filing Date
2023-12-14
Accepted
2023-12-14 08:00:59
Documents
14
Period of Report
2023-12-14
Items
Item 2.01: Completion of Acquisition or Disposition of Assets
Item 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing
Item 3.03: Material Modifications to Rights of Security Holders
Item 5.01: Changes in Control of Registrant
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d557257d8k.htm   iXBRL 8-K 45091
2 EX-3.1 d557257dex31.htm EX-3.1 8859
3 EX-3.2 d557257dex32.htm EX-3.2 88032
  Complete submission text file 0001193125-23-294938.txt   287676

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA sgen-20231214.xsd EX-101.SCH 2875
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE sgen-20231214_lab.xml EX-101.LAB 17981
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE sgen-20231214_pre.xml EX-101.PRE 11275
8 EXTRACTED XBRL INSTANCE DOCUMENT d557257d8k_htm.xml XML 3408
Mailing Address 21823 30TH DRIVE SE SUITE BOTHELL WA 98021
Business Address 21823 30TH DRIVE SE SUITE BOTHELL WA 98021 4255274000
Seagen Inc. (Filer) CIK: 0001060736 (see all company filings)

EIN.: 911874389 | State of Incorp.: WA | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-32405 | Film No.: 231485603
SIC: 2836 Biological Products, (No Diagnostic Substances)